Henry Meds and Wegovy: Semaglutide Options and Program Model

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Part of the PlexusDx Education Hub: practical, evidence-based coverage of GLP-1 therapies, weight-management protocols, and the genetic variables behind them. Browse all Peptides & GLP-1 education

This is an independent editorial review. PlexusDx has no commercial relationship with Henry Meds or the makers of the brands named here, and this page carries no affiliate links or paid placement.

Full head-to-head: PlexusDx vs Henry Meds →

Henry Meds is one of many telehealth brands in the GLP-1 category, and shoppers often search it alongside Wegovy. This review clarifies what Wegovy is, how it relates to Henry's semaglutide offering, and where the two diverge. It is balanced editorial context, not a buying recommendation, current as of April 2026.

What Wegovy is

Wegovy is a brand name for semaglutide, a GLP-1 receptor agonist approved for chronic weight management. As a branded, FDA-approved product it is manufactured and dispensed through retail pharmacies, distinct from the compounded semaglutide that many telehealth programs prepare through 503A pharmacies. Understanding that branded-versus-compounded split is the key to reading any "Henry Meds Wegovy" search accurately.

How Wegovy relates to Henry Meds

Branded versus compounded semaglutide

Henry's model centers on compounded semaglutide made to prescription through a 503A pharmacy, with retail routing available for FDA-approved brand products where applicable. Compounded semaglutide and branded Wegovy share the same active molecule but differ in regulatory status, formulation, and sourcing. Which one you receive depends on the prescription and pharmacy pathway, so confirm specifics with the provider.

What Henry publishes for semaglutide

As verified July 20, 2026, Henry's injectable compounded semaglutide is $297 per month month-to-month, lowering to $247 on the six-month plan ($1,482) and $197 on the twelve-month plan ($2,364, its advertised rate). Sublingual semaglutide is $249 per month with a $179 tier. Branded Wegovy carries its own manufacturer pricing, which you should confirm directly rather than assume from a compounded rate.

The semaglutide evidence base

Semaglutide's weight-management data comes chiefly from the STEP trial program, published in The New England Journal of Medicine in 2021. Semaglutide is a single-target GLP-1 receptor agonist, a different mechanism from dual GIP/GLP-1 agonists like tirzepatide. Trial populations and endpoints vary across studies, and individual outcomes vary; this is research context, not a guaranteed result.

What Henry's program leaves out

Whether semaglutide reaches you as branded Wegovy or a compounded preparation, the prescription alone does not account for the biology receiving it. Variants in GLP1R (semaglutide's receptor target), FTO, MC4R, and TCF7L2 shape satiety, appetite regulation, and glucose handling at the pathway level. They do not predict semaglutide response, but they describe the metabolic terrain a clinician is prescribing into, context no telehealth intake captures.

PlexusDx builds that context in. The Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, including FTO, MC4R, and TCF7L2, so a semaglutide decision begins with your baseline profile.

The PlexusDx semaglutide path

PlexusDx provides semaglutide through its Weight Management Protocols as Semaglutide Injection and Semaglutide Oral, alongside Tirzepatide Injection and Tirzepatide Oral, each paired with upstream genetic insight.

Not affiliated: PlexusDx is not affiliated with Henry Meds and has no commercial relationship with the companies referenced in this article.

Related reading on PlexusDx: Wegovy vs Zepbound, Zepbound vs Wegovy, Wegovy For Weight Loss, Wegovy Cost.

Disclaimer: This article is educational. PlexusDx is not affiliated with Henry Meds and has no commercial relationship with the companies reviewed. PlexusDx offers semaglutide and tirzepatide through its own Weight Management Protocols, and this review compares approaches within the GLP-1 telehealth space. The Precision Peptide Genetic Test analyzes how your genes influence peptide-related biological pathways; it does not predict response to any specific medication. Consult a qualified healthcare provider before beginning any peptide protocol.

Compare the PlexusDx approach: see the Weight Management Protocols, semaglutide and tirzepatide with the genetic context most telehealth programs skip. Or start upstream and take the Precision Peptide Genetic Test to understand your GLP-1 pathway first.

Frequently Asked Questions About Henry Meds and Wegovy

Does Henry Meds prescribe branded Wegovy?

Henry's model centers on compounded semaglutide prepared through a 503A pharmacy, with retail routing available for FDA-approved brands where applicable. Whether branded Wegovy specifically is offered depends on the prescription and pharmacy pathway, so confirm availability and product type directly on Henry's official website before enrolling.

Is compounded semaglutide the same as Wegovy?

They share the same active molecule, semaglutide, but differ in regulatory status, formulation, and sourcing. Wegovy is a branded, FDA-approved product from a retail pharmacy, while compounded semaglutide is made to prescription through a 503A pharmacy. Discuss which you would receive with the prescribing clinician before starting.

How much does Henry charge for semaglutide?

As verified July 20, 2026, injectable compounded semaglutide is $297 per month month-to-month, dropping to $247 on the six-month plan or $197 on the twelve-month plan, the advertised rate. Sublingual semaglutide is $249 with a $179 tier. Branded Wegovy has separate manufacturer pricing you should confirm independently.

Can a genetic test predict how I will respond to Wegovy?

No. The Precision Peptide Genetic Test does not predict response to Wegovy, semaglutide, or any specific drug. It analyzes pathway-level variants such as FTO and MC4R, and TCF7L2 that describe baseline metabolic biology, helpful context for a provider discussion rather than a prediction of outcomes.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.